Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan.
Int J Cancer. 2013 Mar 15;132(6):1249-59. doi: 10.1002/ijc.27961. Epub 2012 Dec 17.
Heterogeneity of tumor tissue has been accounted for in recent years by a hierarchy-based model in which cancer stem cells (CSCs) have the ability both to self-renew and to give rise to differentiated tumor cells and are responsible for the overall organization of a tumor. Research into CSCs has progressed rapidly and concomitantly with recent advances in the biology of normal tissue stem cells, resulting in the identification of CSCs in a wide range of human tumors. Studies of mouse models of human cancer have provided further insight into the characteristics of CSCs as well as a basis for the development of novel therapies targeted to these cells. However, recent studies have revealed complexities, such as plasticity of stem cell properties and clonal diversity of CSCs, in certain tumor types that have led to revision of the original CSC model. In this review, we summarize the history of the discovery and characterization of CSCs, as well as address recent advances that have revealed the complexity of these cells and their therapeutic implications.
近年来,基于层次结构的模型解释了肿瘤组织的异质性,该模型认为癌症干细胞(CSC)具有自我更新和产生分化肿瘤细胞的能力,并且负责肿瘤的整体组织。CSC 的研究进展迅速,同时伴随着正常组织干细胞生物学的最新进展,导致在广泛的人类肿瘤中鉴定出 CSC。对人类癌症的小鼠模型的研究进一步深入了解了 CSC 的特征,并为针对这些细胞的新型治疗方法的发展提供了基础。然而,最近的研究揭示了某些肿瘤类型中干细胞特性的可塑性和 CSC 的克隆多样性等复杂性,这导致对原始 CSC 模型进行了修订。在这篇综述中,我们总结了 CSC 的发现和特征描述的历史,并讨论了最近的进展,这些进展揭示了这些细胞的复杂性及其治疗意义。